⌘K

Login Start Free

Home/Filings/4/0001615219-22-000005

4//SEC Filing

Lammers Paul 4

Accession 0001615219-22-000005

CIK 0001615219other

View on SEC.gov Company Profile

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:05 PM ET

Size

5.2 KB

Accession

0001615219-22-000005

Insider Transaction Report

Form 4

Period: 2022-01-20

Salarius Pharmaceuticals, Inc.SLRX

Director

Transactions

Award
Stock Option (right to buy)
2022-01-20+30,000→ 30,000 total
Exercise: $0.48From: 2023-01-19Exp: 2032-01-19→ Common Stock (30,000 underlying)

Documents

1 file

4
wf-form4_164279908733608.xmlPrimary
FORM 4

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1

filerCIK 0001457289

Filing Metadata

Form type: 4
Filed: Jan 20, 7:00 PM ET
Accepted: Jan 21, 4:05 PM ET
Size: 5.2 KB

View on SEC.gov